Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Sales: 2013-2018

Historic Return on Sales for Armata Pharmaceuticals (ARMP) over the last 4 years, with Dec 2018 value amounting to 22.31%.

  • Armata Pharmaceuticals' Return on Sales rose 10698.00% to 22.31% in Q4 2018 from the same period last year, while for Dec 2018 it was 22.31%, marking a year-over-year increase of 10698.00%. This contributed to the annual value of 9.55% for FY2024, which is 3232.00% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Return on Sales of 22.31% as of Q4 2018, which was down 51.69% from 46.19% recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Return on Sales peaked at 454.34% during Q2 2014, and registered a low of -408.43% during Q3 2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Return on Sales value was -56.16% (recorded in 2016), while the average stood at -60.94%.
  • Examining YoY changes over the last 5 years, Armata Pharmaceuticals' Return on Sales showed a top increase of 38,569bps in 2015 and a maximum decrease of 48,649bps in 2015.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Return on Sales stood at -55.95% in 2014, then skyrocketed by 3,394bps to -22.01% in 2015, then tumbled by 5,515bps to -77.16% in 2016, then plummeted by 751bps to -84.67% in 2017, then soared by 10,698bps to 22.31% in 2018.
  • Its Return on Sales stands at 22.31% for Q4 2018, versus 46.19% for Q3 2018 and -84.67% for Q4 2017.